‌

US Patent 9295666 Bladder cancer treatment and methods

Patent 9295666 was granted and assigned to Spectrum Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Spectrum Pharmaceuticals

Current Assignee

Spectrum Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92956660

Patent Inventor Names

Luigi Lenaz0

Ernie Pfadenhauer0

Guru Reddy0

Jos H. Beijnen0

Bastiaan Nuijen0

Dorla Mirejovsky0

Date of Patent

March 29, 2016

Patent Application Number

140158290

Date Filed

August 30, 2013

Patent Primary Examiner

‌

John Pak

Patent abstract

Therapeutic compositions comprising an indoloquinone compound and various bladder cancer treatments and methods are disclosed. More specifically, the compositions comprise an indoloquinone compound and a formulation vehicle. The formulation vehicle improves the solubility and stability of the indoloquinone compound. Additionally, the coating compositions can include coating agents that provide better adhesion of the coating composition to the bladder wall during intravesical delivery of the coating composition.